Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577301 · ClinicalTrials.gov registry record · NA
Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
A NA study of HIV Infections, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 3
- Study locations
NCT03577301: Completed NA study of HIV Infections, sponsored by Florida State University.
NCT03577301 is a NA study of HIV Infections that has completed, run by Florida State University. The registered enrollment target is 83 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03577301, a NA study of HIV Infections, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 3
- Study locations
Study Summary
YMHP is a counseling intervention program for which the goals are to better understand HIV-prevention focused self-management behaviors among HIV-negative YMSM, and to study the implementation of YMHP to improve portability and scalability. The clinic sites will help investigators to assess and address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce HIV infection among YMSM that reflects the complexities of real world adolescent HIV clinics.
Primary Outcome
The self-reported number of illicit drug use days (not including marijuana) in the past 30 days
Conditions Studied
Interventions
- BEHAVIORAL Clinic-based Delivery
- BEHAVIORAL Remote Delivery
- BEHAVIORAL Multi-modal Delivery
Study Locations (3)
Florida
- University of Miami Miller School of Medicine - Miami
Michigan
- Wayne State University - Detroit
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT03577301 record still lists
NCT03577301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (81% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Clinic-based Delivery is the first listed.
NCT03577301 reports a single indexed study location in Florida, Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03577301 about?
NCT03577301 is a clinical study titled "Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse". YMHP is a counseling intervention program for which the goals are to better understand HIV-prevention focused self-management behaviors among HIV-negative YMSM, and to study the implementation of YMHP to improve portability and scalability. The clinic sites will help investigators to assess and addr...
What is the current status of trial NCT03577301?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2018-10-04. Estimated completion is 2022-05-31.
What conditions does trial NCT03577301 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT03577301?
The interventions under investigation include: Clinic-based Delivery (BEHAVIORAL), Remote Delivery (BEHAVIORAL), Multi-modal Delivery (BEHAVIORAL).
Who is sponsoring clinical trial NCT03577301?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03577301 being conducted?
This trial has 3 study locations across Florida, Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03577301's enrollment target sits among peer trials
83 297th of 542 higher than 245 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI